Efficacy and Safety of Estracyt® in Metastatic Breast Cancer

NCT02853071 · clinicaltrials.gov ↗

PHASE2

Phase

WITHDRAWN

Status

OTHER

Sponsor class

Stopped withdrawal industrial

Conditions

Breast Cancer

Interventions

DRUG: Estramustine
DRUG: standard practice

Sponsor

Centre Hospitalier Universitaire de Besancon